Literature DB >> 7045292

A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy.

M Finlay.   

Abstract

Ten patients with myotonic dystrophy were allocated at random to treatment with disopyramide and procainamide in a cross-over trial. Disopyramide was found to be at least as effective as procainamide in the relief of myotonia; and two patients who could not tolerate procainamide both tolerated disopyramide.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7045292      PMCID： PMC1083128          DOI： 10.1136/jnnp.45.5.461

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  6 in total

1.  Procaine amide in the treatment of myotonia.

Authors:  N GESCHWIND; J A SIMPSON
Journal:  Brain       Date:  1955       Impact factor: 13.501

2.  The treatment of myotonia: a controlled clinical trial.

Authors:  P LEYBURN; J N WALTON
Journal:  Brain       Date:  1959-03       Impact factor: 13.501

3.  Therapy of myotonia. A double-blind evaluation of diphenylhydantoin, procainamide, and placebo.

Authors:  T L Munsat
Journal:  Neurology       Date:  1967-04       Impact factor: 9.910

4.  Incidence, severity, and time-course of motoneurone dysfunction in myotonic dystrophy: their significance for an understanding of anticipation.

Authors:  A J McComas; R E Sica; K Toyonaga
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-10       Impact factor: 10.154

5.  Electrophysiological study of dystrophia myotonica.

Authors:  A J McComas; M J Campbell; R E Sica
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-04       Impact factor: 10.154

6.  Disopyramide phosphate: is it just another quinidine.

Authors:  T Kus; B I Sasyniuk
Journal:  Can J Physiol Pharmacol       Date:  1978-04       Impact factor: 2.273
  6 in total
  3 in total

1.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-06

Review 2.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 3.  Drug treatment for myotonia.

Authors:  J Trip; G Drost; B G M van Engelen; C G Faber
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.